DYNAMICS OF SYNTHESIS AND CIRCULATION OF SUBCLASSES SPECIFIC IgG IN THE IMMUNE RESPONSE TO THE VACCINE AGAINST MEASLES, RUBELLA, MUMPS

Cover Page


Cite item

Full Text

Abstract

The aim of the study was to investigate the dynamics of synthesis and circulation of subclasses of specifi c IgG in the immune response to the Priorix and development of parameters for the separation of primary and secondary types of immune response. The material of the study was the serum samples of children vaccinated against measles, rubella and mumps with Priorix received in 3 weeks after inoculation – 24 children (group 1), in 4 weeks after inoculation – other 26 children (group 2), in 6 weeks – also other 25 children (group 3), 1 year after vaccination – 38 children from the fi rst three groups (group 4), after 5 years (before revaccination) – 24 children from the fourth group (group 5). In the serum samples, the specifi c IgG antibodies and the spectrum of their subclasses against measles, rubella and mumps viruses were studied using the enzyme immunoassay. It was shown that at the beginning of the immune response to all three viruses, IgG3 subclass antibodies were formed, but the rate of growth and switching to a predominantly IgG1-type immune response was diff erent. Cut off was calculated for the antibodies of subclasses IgG1 and IgG3, which were 46.84% and 42.8% for measles virus, respectively; for rubella viruses 62.67% and 12.63% respectively; for the mumps virus 54.97% and 37.26% respectively. The cut off values obtained make it possible to separate the primary and secondary immune response by the ratio of the antibody subclasses. The importance of the developed approach to the separation of early and late type immune response in vaccinated was confi rmed in an independent group of vaccinated children: 16 people 4 weeks after inoculation and 15 children one year after vaccination Priorix, as well as in the study of antibodies in serum from patients with measles adults (14 not previously vaccinated patients and 15 vaccinated in childhood patients).

About the authors

A. P. Toptygina

G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology

Author for correspondence.
Email: toptyginaanna@rambler.ru

PhD, MD (Medicine), Leading Research Associate, Laboratory of Cytokines,

125212 Moscow, Admirala Makarova ul., 10

Russian Federation

T. A. Mamaeva

G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology

Email: fake@neicon.ru

PhD (Biology), Leading Research Associate, Laboratory of Immunochemistry,

Moscow

Russian Federation

References

  1. Strebel P. M., Cochi S. L., Hoekstra E., Rota P. A., Featherstone D., Bellini W. J., Katz S. L. A world without measles. J Infect Dis 2011, 204, Suppl 1: S1–3.
  2. European Centre for Disease Prevention and Control (ECDC). Epidemiological update: Measles – monitoring European outbreaks, 7 July 2017. Stockholm: ECDC; [Accessed 31 Aug 2017]. Available from: https://ecdc. europa.eu/en/news-events/epidemiological-updatemeasles-monitoring-european-outbreaks-7-july-2017
  3. World Health Organization Regional Office for Europe (WHO/Europe). Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) 24–26 October 2016, Copenhagen, Denmark. Copenhagen: WHO/Europe; [Accessed 31 Aug 2017]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0005/330917/5th-RVCmeeting-report.pdf?ua=1
  4. Топтыгина А.П., Мамаева Т. А., Алешкин В. А. Особенности специфического гуморального иммунного ответа против вируса кори. Инфекция и иммунитет, 2013, 3, № 3, 243–250.
  5. Erdman D., Heath J. L., Watson J. C., Markowitz L. E., Bellini W. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J. Med. Virol 1993, 41, 44–48.
  6. Мамаева Т. А., Липская Г. Ю., Наумова М. А., Шульга С. В., Mulders M., Featherstone D. A., Завьялова Л. А., Чернышова Е. В., Замятина Е. П., Кузнецова Н. Н. Особенности лабораторной диагностики кори у больных с разным прививочным анамнезом. Вопр. Вирусол. 2012, 5, 21–26.
  7. Топтыгина А. П., Алешкин В. А. Сопоставление первичного и вторичного гуморального иммунного ответа на вакцинацию «Приорикс». Инфекция и иммунитет 2013, 3, 4, 359–364.
  8. Toptygina A. P., Pukhalsky A. L., Alioshkin V. A. IgG subclass profi le of antimeasles response in vaccinated children and adults with measles history. Clin. Diag. Lab. Immunol. 2005, 12, 7, 845–847.
  9. Топтыгина А. П., Семикина Е. Л., Копыльцова Е. А., Алешкин В. А. Возрастные особенности формирования гуморального звена иммунного ответа у детей. Медицинская Иммунология 2012, 14, 4–5, 289–294.
  10. Топтыгина А. П., Пухальский А. Л., Мамаева Т. А., Алешкин В. А. Спектр субклассов противокоревых иммуноглобулинов G у лиц, перенесших корь. Бюлл. экспер. биол. 2004, 137, 3, 293–295.
  11. Erlenhöfer C., Wurzer W. J., Loffler S., Shneider-Schaulies S., ter Meulen V., Schneider-Schaulies J. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J. Virol. 2001, 75, 4499–4505.
  12. Qi H., Cannons J. L., Klauschen F., Schwartzberg P. L., Germain R. N. SAP-controlled T-B cell interactions underlie germinal center formation Nature 2008, 455, 764–769.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Toptygina A.P., Mamaeva T.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies